midazolam has been researched along with sb 203580 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akamatsu, S; Dohi, S; Kato, K; Kozawa, O; Suga, H; Takai, S; Tanabe, K | 1 |
Ghori, K; O'Driscoll, J; Shorten, G | 1 |
2 other study(ies) available for midazolam and sb 203580
Article | Year |
---|---|
Midazolam suppresses thrombin-induced heat shock protein 27 phosphorylation through inhibition of p38 mitogen-activated protein kinase in cardiac myocytes.
Topics: Anesthetics, Intravenous; Animals; Heat-Shock Proteins; Imidazoles; JNK Mitogen-Activated Protein Kinases; Mice; Midazolam; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Thrombin | 2005 |
The effect of midazolam on neutrophil mitogen-activated protein kinase.
Topics: CD11b Antigen; CD18 Antigens; Enzyme Inhibitors; Humans; Hypnotics and Sedatives; Imidazoles; Midazolam; Neutrophils; p38 Mitogen-Activated Protein Kinases; Pyridines; Reperfusion Injury | 2010 |